Incannex Healthcare Inc.
For the period ended Sep 30, 2025. Filed Nov 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 14, 2025
IXHL$2.19-2.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| September 30, 2025 | June 30, 2025 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $73,280 | $15,039 |
| Prepaid expenses and other assets | 486 | 791 |
| Research and Development (“R&D”) tax incentive receivable | 4,529 | 4,132 |
| Total current assets | 78,295 | 19,962 |
| Property, plant and equipment, net | 168 | 227 |
| Investment in Joint Venture | 45 | - |
| Operating lease right-of-use assets | 212 | 258 |
| Total assets | $78,720 | $20,447 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Trade and other payables | $1,296 | $6,104 |
| Accrued expenses and other current liabilities | 206 | 696 |
| Operating lease liabilities, current | 146 | 184 |
| Total current liabilities | 1,648 | 6,984 |
| Operating lease liabilities, non-current | 64 | 74 |
| Total liabilities | 1,712 | 7,058 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ equity: | ||
| Common stock, $0.0001 par value – shares 800,000,000 authorized; 347,705,507 and 194,379,996 shares issued and outstanding at September 30, 2025 and June 30, 2025 respectively | 35 | 20 |
| Preferred stock, $0.0001 par value per share, 10,000,000 shares authorized; no shares issued or outstanding at September 30, 2025 and June 30, 2025, respectively | - | - |
| Additional paid-in capital | 243,837 | 174,049 |
| Accumulated deficit | (163,963) | (157,556) |
| Foreign currency translation reserve | (2,901) | (3,124) |
| Total stockholders’ equity | 77,008 | 13,389 |
| Total liabilities and stockholders’ equity | $78,720 | $20,447 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.